About Pamela Steele
Form D filings for Flow Pharma from 2022 to 2024 list Pamela Steele as director.
Pamela Steele first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Pamela Steele in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Pamela Steele works with at each company, as listed on that company's latest Form D.
Flow Pharma, Inc. · Form D/A, Aug 8, 2024
AT
Anthony Tufaro
Director
RR
Reid Rubsamen
Chief Executive Officer and director
TB
Tikoes Blankenberg
Director
BO
Babatunde Otulana
Director